Skip to content

Discontinued — last reported Q1 '25

Gross Profit at other companies

IAR
Integra LifeSciencesIART
$216.98M+11.6%
MiMedx Group logo
MiMedx GroupMDXG
$41.62M-41.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$139.55M+14.7%
Bioventus logo
BioventusBVS
$90.77M+9.3%
Axogen logo
AxogenAXGN
$46.19M+32.2%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$48.4M+16.8%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s gross profit?
Organogenesis Holdings Inc. (ORGO) reported gross profit of $62.97M in Q1 2025.
How has Organogenesis Holdings Inc.'s gross profit changed year-over-year?
Organogenesis Holdings Inc.'s gross profit decreased by 22.5% year-over-year, from $81.28M to $62.97M.
What is the long-term trend for Organogenesis Holdings Inc.'s gross profit?
Over 3 years (2021 to 2024), Organogenesis Holdings Inc.'s gross profit has grown at a 1.2% compound annual growth rate (CAGR), from $353.16M to $366.3M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.